Fisher & Paykel Healthcare Corporation Limited provides revenue guidance for the financial year ending 31 March 2023. The company expects full year operating revenue for the 2023 financial year to be within the range of approximately $1.55 billion to $1.60 billion.
Fisher & Paykel Healthcare Corporation Limited
Equities
FPH
NZFAPE0001S2
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.89 NZD | +0.30% | -0.63% | +26.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.65% | 10.71B | |
-5.50% | 181B | |
-5.79% | 99.52B | |
-6.59% | 65.82B | |
-8.38% | 45.21B | |
+8.42% | 43.85B | |
+10.10% | 42.17B | |
+10.97% | 28.75B | |
+18.89% | 25.39B | |
-8.39% | 23.5B |
- Stock Market
- Equities
- FPH Stock
- News Fisher & Paykel Healthcare Corporation Limited
- Fisher & Paykel Healthcare Corporation Limited Provides Revenue Guidance for the Financial Year Ending 31 March 2023